The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change
6 affiliations
- 1Department of Radiation Oncology Princess Margaret Cancer Centre, University of Toronto Toronto Ontario Canada
- 2Belgian Cancer Registry Brussels Belgium
- 3Cambridge University Hospitals NHS Foundation Trust Cambridge UK
- 4Keio University School of Medicine Tokyo Japan
- 5Department of Clinical Oncology University of Hong Kong Hong Kong Hong Kong
- 6Department of Radiology, Radiation Oncology and Nuclear Medicine Centre Hospitalier de l'Universite de Montreal, University of Montreal Montreal Canada
Abstract
The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s. Due to the expanding medical knowledge of tumour behaviour and advances in imaging, pathology and therapeutic options, TNM has been updated in collaboration with the American Joint Committee on Cancer (AJCC), the International Association for the study of Lung Cancer (IASLC) and the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) on a regular basis. The 9th edition of the UICC TNM Classification of Malignant Tumours has recently been published. This review summarized the changes between the 8th and 9th edition. The evidence basis used for revision is described and referenced, with a focus on the changes in head and neck and lung cancers.
Related
- En bloc temporo-parotid resection for malignant tumours of the parotid: surgical technique.
- Predicting Textbook Oncological Outcomes with Machine Learning: A Retrospective Review of Patients Who Underwent Resection for Malignant Tumours
- A proteome-based classification of paediatric adrenocortical tumours links functional tumour states to clinical outcome and therapeutic vulnerabilities.
- Anomaly Localization and Classification of Jaw Cysts and Tumours Using Anatomy-Conditioned Diffusion on Panoramic Radiographs
- The Spectrum of Eyelid Lesions: Histopathologic Classification of Benign, Malignant, and Non-Neoplastic Findings
BibTeX
@article{brierley2026edition,
title = {{The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change}},
author = {James D. Brierley and Liesbet J. Van Eycken and Meredith Giuliani and Brian Rous and Sicong Huang and Hisao Asamura and Mary K. Gospodarowicz and Anne W. Lee and Brian O’Sullivan},
journal = {International Journal of Cancer},
year = {2026},
month = jun,
doi = {10.1002/ijc.70561},
url = {https://doi.org/10.1002/ijc.70561},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - The 9th Edition of the UICC TNM Classification of Malignant Tumours: Updates and Rationale for Change
AU - James D. Brierley
AU - Liesbet J. Van Eycken
AU - Meredith Giuliani
AU - Brian Rous
AU - Sicong Huang
AU - Hisao Asamura
AU - Mary K. Gospodarowicz
AU - Anne W. Lee
AU - Brian O’Sullivan
PY - 2026
DA - 2026/06/09
JO - International Journal of Cancer
DO - 10.1002/ijc.70561
UR - https://doi.org/10.1002/ijc.70561
AB - The standard for assessing and recording the extent of the tumour, a necessity for most malignancies, is the Tumour Node Metastases (TNM) classification. The Union for International Cancer Control (UICC) TNM committee has defined this since the early 1950s. Due to the expanding medical knowledge of tumour behaviour and advances in imaging, pathology and therapeutic options, TNM has been updated in collaboration with the American Joint Committee on Cancer (AJCC), the International Association for the study of Lung Cancer (IASLC) and the Federation Internationale de Gynecologie et d'Obstetrique (FIGO) on a regular basis. The 9th edition of the UICC TNM Classification of Malignant Tumours has recently been published. This review summarized the changes between the 8th and 9th edition. The evidence basis used for revision is described and referenced, with a focus on the changes in head and neck and lung cancers.
SN - 0020-7136
SN - 1097-0215
ER -